(a) A drug or device is not subject to the labeling or packaging requirements of this subtitle if a rule or regulation is adopted under the federal act or as provided under this section to exempt it.
(b) The Secretary shall adopt rules and regulations to exempt from the labeling requirements of this subtitle any drug or device that is to be transported in substantial quantities from one establishment to another, if in accordance with the practice of the trade, the drug or device is to be processed, labeled, or repacked at the second establishment.
Structure Maryland Statutes
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2 - Maryland Food, Drug, and Cosmetic Act
Section 21-216 - Adulterated Drugs and Devices
Section 21-217 - Misbranded Drugs and Devices -- in General
Section 21-218 - Additional Grounds of Drug Misbranding
Section 21-220 - Prescription Requirements
Section 21-222 - Construction of 21-220 and 21-221
Section 21-223 - New Drugs -- in General
Section 21-224 - New Drugs -- Exemption When Intended for Investigational Use Only
Section 21-225 - New Drugs -- Inspection of Records
Section 21-226 - Printed Information for Use of Practitioners
Section 21-227 - Provision of Information on Request of Secretary